171 related articles for article (PubMed ID: 11327052)
1. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis.
Kato M; Mano H; Ota A; Konomi K; Nakata K
J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
Okumura N; Fukushima A; Igarashi A; Sumi T; Yamagishi T; Ueno H
J Ocul Pharmacol Ther; 2006 Oct; 22(5):347-52. PubMed ID: 17076629
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor in human normal tears.
Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of platelet-activating factor in the guinea-pig heart.
Triggiani M; Chilton FH
J Mol Cell Cardiol; 1992 Oct; 24(10):1101-11. PubMed ID: 1479612
[TBL] [Abstract][Full Text] [Related]
5. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs.
Kato M; Imoto K; Miyake H; Oda T; Miyaji S; Nakamura M
J Pharmacol Sci; 2004 Aug; 95(4):435-42. PubMed ID: 15286429
[TBL] [Abstract][Full Text] [Related]
6. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis.
Kato M; Kurose T; Oda T; Miyaji S
J Ocul Pharmacol Ther; 2003 Aug; 19(4):315-24. PubMed ID: 12964956
[TBL] [Abstract][Full Text] [Related]
7. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
9. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
[TBL] [Abstract][Full Text] [Related]
10. Role of substance P in experimental allergic conjunctivitis in guinea pigs.
Yamaji M; Takada M; Fujiwara R; Ohishi H; Izushi K; Sugimoto Y; Kamei C
Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):637-43. PubMed ID: 9500128
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide induces vascular permeability changes in the guinea pig conjunctiva.
Meijer F; Ruijter JM; Van Delft JL; Van Haeringen NJ
Eur J Pharmacol; 1995 Sep; 284(1-2):61-7. PubMed ID: 8549637
[TBL] [Abstract][Full Text] [Related]
12. Possible influence of lysophospholipase on the production of 1-acyl-2-acetylglycerophosphocholine in macrophages.
Nakagawa Y; Sugai M; Karasawa K; Tokumura A; Tsukatani H; Setaka M; Nojima S
Biochim Biophys Acta; 1992 Jun; 1126(3):277-85. PubMed ID: 1637856
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.
Yanoshita R; Kudo I; Ikizawa K; Chang HW; Kobayashi S; Ohno M; Nojima S; Inoue K
J Biochem; 1988 May; 103(5):815-9. PubMed ID: 3182751
[TBL] [Abstract][Full Text] [Related]
14. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release.
Touqui L; Herpin-Richard N; Gene RM; Jullian E; Aljabi D; Hamberger C; Vargaftig BB; Dessange JF
J Allergy Clin Immunol; 1994 Jul; 94(1):109-19. PubMed ID: 8027488
[TBL] [Abstract][Full Text] [Related]
15. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
16. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
[TBL] [Abstract][Full Text] [Related]
17. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
Stock EL; Roth SI; Kim ED; Walsh MK; Thamman R
Invest Ophthalmol Vis Sci; 1990 May; 31(5):987-92. PubMed ID: 2335460
[TBL] [Abstract][Full Text] [Related]
18. Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipase and platelet-activating-factor acetylhydrolase.
Aarsman AJ; Neys FW; Van den Bosch H
Eur J Biochem; 1991 Aug; 200(1):187-93. PubMed ID: 1879423
[TBL] [Abstract][Full Text] [Related]
19. Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients.
Denizot Y; Gainant A; Guglielmi L; Bouvier S; Cubertafond P; Mathonnet M
Oncogene; 2003 Oct; 22(46):7222-4. PubMed ID: 14562051
[TBL] [Abstract][Full Text] [Related]
20. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.
Triggiani M; De Marino V; Sofia M; Faraone S; Ambrosio G; Carratù L; Marone G
Am J Respir Crit Care Med; 1997 Jul; 156(1):94-100. PubMed ID: 9230731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
